MilliporeSigma Opens New Life Science Center in Massachusetts for Scientific Collaboration

Massachusetts Gov. Charlie Baker and company executive board members cut the ribbon on new Life Science Center – Burlington Company convenes scientific symposium with leaders in Genome Editing, eCommerce and Big Data New Life Science Center includes an M Lab™ Collaboration Center and region’s first BioReliance® Biodevelopment Center Burlington, Massachusetts, October 11, 2017 — MilliporeSigma today... Read more

MilliporeSigma Introduces Eshmuno® P Anti-A and Anti-B Chromatography Resins for Enhancement of Plasma-Derived Immunoglobulin

Increased safety for patients undergoing immunoglobulin treatment Excellent stability for longer product lifetime Higher quality control with improved product release test Billerica, Massachusetts, September 20, 2017 — MilliporeSigma today launched Eshmuno® P anti-A and Eshmuno® P anti-B affinity chromatography resins specifically designed to remove anti-A and anti-B isoagglutinin antibodies during the manufacturing of plasma-derived immunoglobulin (Ig) therapies.Trace amounts of... Read more

MilliporeSigma Opens its First Customer Food Safety Studio

New Food Safety Studio in Bellevue, Washington, serves as global center for innovation and collaboration Demonstration and training lab space extends product and process development to customers Billerica, Massachusetts, August 30, 2017 — MilliporeSigma has opened its first global Food Safety Studio in Bellevue, Washington for manufacturers of all types of food (beef, poultry, produce, etc.) to collaborate... Read more

MilliporeSigma to Acquire Natrix Separations to Advance Next-Generation Processing Capabilities

Boosts MilliporeSigma’s single-use chromatography portfolio Accelerates MilliporeSigma’s mAb and vaccine manufacturing offering Billerica, Massachusetts, August 28, 2017 — MilliporeSigma today announced that it has entered into an agreement to acquire Natrix Separations, an Ontario, Canada-based provider of hydrogel membrane products for single-use chromatography. The transaction is expected to close in Q3 of 2017. Financial details were not disclosed.... Read more

European Patent Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology

Patent application covers integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR Related patent application recently awarded in Australia; similar patents pending in other countries, favorable outcomes anticipated Billerica, Massachusetts, August 3, 2017 — MilliporeSigma today announced that the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for MilliporeSigma’s... Read more